Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-04

Clinical Trial Update: A Study CLBG and Benzoyl Peroxide Gel 1%/5% to BenzaClin® Gel in the Treatment of Acne Vulgaris [Phase 1]

View source ↗

Summary

Phase 1 study comparing CLBG and benzoyl peroxide gel (1%/5%) to BenzaClin Gel for acne vulgaris; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BenzaClin Gel (benzoyl peroxide 5% / clindamycin phosphate 1%)
  • Benzoyl Peroxide Gel 1%/5% (benzoyl peroxide 1% or 5%)
  • CLBG

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Acne Vulgaris | Phase 1 | Status: COMPLETED